文献速递精神分裂症与精神病性障碍

精神分裂症患者的大脑衰老加速:ENIGMA联盟26个国际队列研究

Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium.
PubMed 文献 · Mol Psychiatry · 2022-12-09

该研究由ENIGMA精神分裂症工作组开展前瞻性荟萃分析,纳入全球26个队列共2803例精神分裂症患者和2598名健康对照,基于T1加权MRI数据估计大脑预测年龄。结果显示患者的大脑预测年龄差(brain-PAD)平均比对照高3.55年(95%CI:2.91,4.19),提示精神分裂症存在结构性大脑衰老加速。

要点

  • 精神分裂症患者brain-PAD平均比健康对照高3.55年(95%CI:2.91,4.19)。
  • brain-PAD与发病年龄、病程、症状严重度及抗精神病药使用和剂量无关。
  • 该研究提示精神分裂症存在结构性大脑衰老加速,需纵向研究评估临床意义。

核心结论

  • 这项大规模协作研究提示精神分裂症患者存在结构性大脑衰老加速。

研究设计与样本

  • 由ENIGMA精神分裂症工作组开展前瞻性荟萃分析,纳入全球26个队列共2803例精神分裂症患者和2598名健康对照。
  • 基于独立的T1加权脑MRI数据训练模型,使用68项皮层厚度和表面积测量、7项皮层下体积、侧脑室体积和总颅内体积估计个体大脑预测年龄。

主要发现

  • 调整年龄、性别和站点后,精神分裂症患者的brain-PAD平均比对照高3.55年(95%CI:2.91,4.19;I2=57.53%;Cohen's d=0.48)。
  • 在精神分裂症患者中,brain-PAD与发病年龄、病程、症状严重度或抗精神病药使用和剂量均无关。

临床怎么用

  • brain-PAD可作为评估精神分裂症患者结构性大脑衰老的潜在影像学指标,但当前未发现其与特定临床特征相关。

局限性

  • 原文未明确报告局限性;作者指出需纵向研究进一步评估brain-PAD升高及其可干预性的临床意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Schizophrenia (SZ) is associated with an increased risk of life-long cognitive impairments, age-related chronic disease, and premature mortality. We investigated evidence for advanced brain ageing in adult SZ patients, and whether this was associated with clinical characteristics in a prospective meta-analytic study conducted by the ENIGMA Schizophrenia Working Group. The study included data from 26 cohorts worldwide, with a total of 2803 SZ patients (mean age 34.2 years; range 18-72 years; 67% male) and 2598 healthy controls (mean age 33.8 years, range 18-73 years, 55% male). Brain-predicted age was individually estimated using a model trained on independent data based on 68 measures of cortical thickness and surface area, 7 subcortical volumes, lateral ventricular volumes and total intracranial volume, all derived from T1-weighted brain magnetic resonance imaging (MRI) scans. Deviations from a healthy brain ageing trajectory were assessed by the difference between brain-predicted age and chronological age (brain-predicted age difference [brain-PAD]). On average, SZ patients showed a higher brain-PAD of +3.55 years (95% CI: 2.91, 4.19; I2 = 57.53%) compared to controls, after adjusting for age, sex and site (Cohen's d = 0.48). Among SZ patients, brain-PAD was not associated with specific clinical characteristics (age of onset, duration of illness, symptom severity, or antipsychotic use and dose). This large-scale collaborative study suggests advanced structural brain ageing in SZ. Longitudinal studies of SZ and a range of mental and somatic health outcomes will help to further evaluate the clinical implications of increased brain-PAD and its ability to be influenced by interventions.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Constantinides C, Han LKM, Alloza C, et al. Brain ageing in schizophrenia: evidence from 26 international cohorts via the ENIGMA Schizophrenia consortium. Mol Psychiatry. 2022. PMID: 36494461. doi:10.1038/s41380-022-01897-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。